J&J v. Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Wilmington, Delaware federal court sets aside stent patent infringement award of $271.1 mil. to Johnson & Johnson, Medtronic announces April 1. In a similar patent dispute between Boston Scientific and J&J, the same federal judge set aside a jury award of $324.4 mil. (1"The Gray Sheet" April 1, 2002, In Brief). J&J plans to appeal...
You may also be interested in...
J&J v. Boston Scientific
Stent patent infringement award of $324.4 mil. to Johnson & Johnson is set aside and a new damages trial has been ordered in Wilmington federal court, Boston Scientific announces March 28. However, the court upheld a portion of a December 2000 jury verdict that found the NIR stent, made by Medinol for Boston Scientific, infringed one claim of J&J's '762 Palmaz balloon expandable stent patent (1"The Gray Sheet" Dec. 18, 2000, p. 16). "Regardless of the outcome of the new damages trial, we plan on appealing any infringement judgment entered," Boston Scientific says...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.